Medicare Enrolled
Dr. Michael Zavaski, MD
Urology Physician · Springfield, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zavaski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zavaski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zavaski
Dr. Michael Zavaski is an urology physician in Springfield, MA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Zavaski performed 10,674 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Zavaski received a total of $22,402 from 18 pharmaceutical and/or device companies across 52 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zavaski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years of NPI registration
▲ Top 5% volume in MA
$22,402 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗10,674
Medicare services
Top 5% in MA for urology physician
Not available
Unique patients (not deduplicated)
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 2,045 | $2 | $4 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
1,534 | $34 | $80 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
853 | $90 | $300 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
840 | $2 | $6 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
644 | $61 | $200 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
590 | $34 | $87 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
549 | $8 | $55 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
504 | $7 | $7 |
| PSA test (prostate cancer screening) | 430 | $18 | $50 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
354 | $69 | $325 |
| Cell examination with selective cellular enhancement A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis. |
237 | $32 | $200 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 172 | $134 | $575 |
| Manual urine cell examination A laboratory test where a technician manually examines a urine sample under a microscope to identify and count cells. |
168 | $450 | $1,500 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
130 | $110 | $550 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
123 | $113 | $430 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
118 | $34 | $85 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
118 | $34 | $200 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
118 | $34 | $100 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
118 | $34 | $80 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
117 | $55 | $250 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
107 | $18 | $50 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
96 | $5 | $12 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
96 | $4 | $10 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
85 | $8 | $20 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
59 | $22 | $185 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
51 | $67 | $300 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
47 | $51 | $225 |
| Electrolyte blood test panel A blood test that measures the levels of sodium, potassium, chloride, and carbon dioxide to evaluate electrolyte balance. |
44 | $7 | $16 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
35 | $27 | $85 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
32 | $86 | $425 |
| Simple change of bladder tube | 30 | $67 | $225 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
28 | $20 | $44 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
25 | $25 | $55 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
24 | $4 | $10 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
24 | $145 | $400 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
23 | $207 | $800 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
23 | $157 | $2,191 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
17 | $128 | $882 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
16 | $92 | $875 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
14 | $24 | $90 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $40 | $120 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
12 | $105 | $821 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
11 | $4 | $9 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.3% high complexity
8.4% medium
91.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,402
Total received (2018-2024)
Avg $3,200/year across 7 years
Top 11% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
18
Companies
52
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$266
2023
$3,430
2022
$4,110
2021
$10,474
2020
$3,962
2019
$126
2018
$34
Payments by company (2024)
Ferring Pharmaceuticals Inc.
$85
ABBVIE INC.
$50
ACCORD HEALTHCARE, INC.
$45
Laborie Medical Technologies Corp.
$31
Endo Pharmaceuticals Inc.
$21
Endo USA, Inc.
$18
Sumitomo Pharma America, Inc.
$16
Top 3 companies account for 67.6% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$11,579
BOSTON SCIENTIFIC CORPORATION
$10,125
Sumitomo Pharma America, Inc.
$179
Olympus America Inc.
$108
Ferring Pharmaceuticals Inc.
$85
ABBVIE INC.
$50
ACCORD HEALTHCARE, INC.
$45
Teleflex LLC
$33
Laborie Medical Technologies Corp.
$31
UroGen Pharma, Inc.
$24
Endo Pharmaceuticals Inc.
$21
AbbVie Inc.
$21
TOLMAR Pharmaceuticals, Inc.
$19
Endo USA, Inc.
$18
AbbVie, Inc.
$18
Baudax Bio Inc.
$16
PFIZER INC.
$15
Axonics Modulation Technologies, Inc.
$15
Top 3 companies account for 97.7% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ANJESO · AVEED · Axonics r-SNM System · BOTOX · CAMCEVI · ELIGARD · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL KIDNEY STONE DISEASE · GENERAL - KIDNEY STONE DISEASE · General - Kidney Stone Disease · JELMYTO · LithoVue · Lupron Depot · Moses 550 D\F\L · Olympus Cysto-Resection · Optilume BPH Drug Coated Balloon Catheter · UROLIFT · XTANDI
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
36
County median income
$70,535
Nearest hospital to ZIP centroid (approximate)
MERCY MEDICAL CTR
2.2 mi
2.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zavaski is a clinical cardiology specialist, with above-average Medicare volume (top 5% in MA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zavaski experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Zavaski performed 2,045 bcg treatment for bladder cancer services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Zavaski receive payments from pharmaceutical companies?
Yes. Dr. Zavaski received a total of $22,402 from 18 companies across 52 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zavaski's costs compare to other urology physicians in Springfield?
Dr. Zavaski's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zavaski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Springfield
Browse urology physicians in Springfield ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MA
Which MA urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology